Two Antibody Drugs Found To Be Ineffective Against Omicron

Two of three antibody treatments for COVID-19 have been de-authorized after the manufacturers announced they were ineffective against the omicron variant.

The FDA has de-authorized two antibody drugs used for to fight COVID-19 infections after drugmakers Eli Lilly and Regeneron announced the infusion drugs don’t work against the Omicron variant which now accounts for 99% of U.S. infections. Continue reading “Two Antibody Drugs Found To Be Ineffective Against Omicron”